{"id":"W2888974667","doi":"10.1016/j.clml.2018.07.090","title":"Treatment-Free Remission (TFR) in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) and Stable Deep Molecular Response (DMR) Discontinuing Dasatinib (DASFREE)","year":2018,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Dasatinib; Discontinuation; Myeloid leukemia; Medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Internal medicine; Imatinib; Oncology; Cancer research; Receptor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005350094,0.0001649106,0.0005227492,0.0002841804,0.0002718701,0.0005329448,0.0002026327,0.0003990796,0.001405989],"category_scores_gemma":[0.001160306,0.00008571876,0.0004486178,0.0003789118,0.0002288747,0.0005702521,0.0003488854,0.0005844256,0.0001577583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004466631,"about_ca_system_score_gemma":0.0004397492,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001579401,"about_ca_topic_score_gemma":0.003882848,"domain_scores_codex":[0.9996814,0.0000921227,0.00003412772,0.00005682436,0.00003895182,0.00009660749],"domain_scores_gemma":[0.9994953,0.0001350106,0.0001723593,0.00002081644,0.00002348751,0.0001530533],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02708003,0.0004582173,0.8649431,0.0002315094,0.0003544078,0.0007669912,0.0002219588,0.0006531401,0.002868748,0.0003930839,0.002830582,0.09919813],"study_design_scores_gemma":[0.00122742,0.005651367,0.9851922,0.00005206109,0.0002567799,0.001808592,0.0002852706,0.0007481349,0.0004381073,0.0005873558,0.003735561,0.00001714451],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936169,0.002936928,0.0001228753,0.0004220536,0.00003666001,0.00003561169,0.0007126336,0.00001436637,0.002101904],"genre_scores_gemma":[0.9984225,0.0003150059,0.00007194473,0.0001847545,0.00002718349,0.00001176152,0.000760309,0.000002070488,0.0002046345],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001579401,"threshold_uncertainty_score":0.004703462,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01515363762114324,"score_gpt":0.3076260359295255,"score_spread":0.2924723983083822,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}